Prostate Cell News

@ProstateCell

An online resource for researchers studying prostate cells and prostate cancer. Part of the @STEMCELLTech Science News service.

Joined June 2010

302Following

2KFollowers

Prostate Cell News@ProstateCell · Jul 25

This @MolOncology study by Dr. @dl_goode and team redefines focal neuroendocrine differentiation as a distinct #prostate cancer pathology. 🔎 Discover more: bit.ly/4lWjB1G

ProstateCell's tweet image. This @MolOncology study by Dr. @dl_goode and team redefines focal neuroendocrine differentiation as a distinct #prostate cancer pathology.

🔎 Discover more: bit.ly/4lWjB1G

120

Prostate Cell News@ProstateCell · Jul 25

Hear from Dr. Cathi Murphey as she discusses the validation of cell isolation technologies for isolating different cell subsets and improving purity for #chimerism analysis in this @STEMCELLTech webinar. 🥼 bit.ly/3FCBkvi

ProstateCell's tweet image. Hear from Dr. Cathi Murphey as she discusses the validation of cell isolation technologies for isolating different cell subsets and improving purity for #chimerism analysis in this @STEMCELLTech webinar. 🥼

bit.ly/3FCBkvi

Prostate Cell News@ProstateCell · Jul 24

Researchers investigated the regulation and function of PD-1 expression in #ProstateCancer and revealed the impact on the tumor microenvironment. 💡 Learn more in @CR_AACR: bit.ly/3UhJixT

ProstateCell's tweet image. Researchers investigated the regulation and function of PD-1 expression in #ProstateCancer and revealed the impact on the tumor microenvironment.

💡 Learn more in @CR_AACR: bit.ly/3UhJixT

Prostate Cell News@ProstateCell · Jul 24

Scientists engineered an enhanced PSMA/CD3 bispecific antibody by incorporating the extracellular domain of CD80, which provides a co-stimulatory signal to counteract T-cell inhibition in #ProstateCancer. 📖 Discover more: bit.ly/46Zp3fD

ProstateCell's tweet image. Scientists engineered an enhanced PSMA/CD3 bispecific antibody by incorporating the extracellular domain of CD80, which provides a co-stimulatory signal to counteract T-cell inhibition in #ProstateCancer.

📖 Discover more: bit.ly/46Zp3fD

101

Prostate Cell News@ProstateCell · Jul 23

Dr. Neil Bhowmick and colleagues depletion of glutamine with a cyanobacteria-derived catalytic aptamer blocks FGF8 expression and sensitizes hormone refractive prostate tumors to androgen receptor inhibitors. 🩺 @CR_AACR | bit.ly/46fHmNo

$ProstateCell's tweet image. Dr. Neil Bhowmick and colleagues depletion of glutamine with a cyanobacteria-derived catalytic aptamer blocks FGF8 expression and sensitizes hormone refractive prostate tumors to androgen receptor inhibitors. 🩺 @CR_AACR | bit.ly/46fHmNo$

103

Prostate Cell News@ProstateCell · Jul 22

Today in @NatureGenet! Scientists report a hierarchical network of TFs governed by NKX2-1 in critically regulating chromatin remodeling and driving luminal-to-neuroendocrine transformation in neuroendocrine #ProstateCancer. 🌐 go.nature.com/4lCMu2N

ProstateCell's tweet image. Today in @NatureGenet!

Scientists report a hierarchical network of TFs governed by NKX2-1 in critically regulating chromatin remodeling and driving luminal-to-neuroendocrine transformation in neuroendocrine #ProstateCancer. 🌐

go.nature.com/4lCMu2N

147

Prostate Cell News@ProstateCell · Jul 18

🔎 Scientists investigated #androgen receptor involvement in pain sensitivity and sex differences in pain perception. Manipulating androgen signaling in sensory neurons may offer a promising approach to managing mechanical pain. 🔗 bit.ly/3GvWjR9

ProstateCell's tweet image. 🔎 Scientists investigated #androgen receptor involvement in pain sensitivity and sex differences in pain perception.

Manipulating androgen signaling in sensory neurons may offer a promising approach to managing mechanical pain.

🔗 bit.ly/3GvWjR9

Prostate Cell News@ProstateCell · Jul 17

🔬 Researchers created an urinary large extracellular vesicles-centric proteomic approach for early prostate cancer identification. @an_chem | bit.ly/3IsSo8j

ProstateCell's tweet image. 🔬 Researchers created an urinary large extracellular vesicles-centric proteomic approach for early prostate cancer identification.

@an_chem | bit.ly/3IsSo8j

Prostate Cell News@ProstateCell · Jul 16

🦠 The antitumor activity of a 56mer aptamer helped support glutamine as an oncometabolite in prostate adenocarcinoma that can be targeted to sensitize tumors to hormone therapy. @CR_AACR | bit.ly/46fHmNo

ProstateCell's tweet image. 🦠 The antitumor activity of a 56mer aptamer helped support glutamine as an oncometabolite in prostate adenocarcinoma that can be targeted to sensitize tumors to hormone therapy.

@CR_AACR | bit.ly/46fHmNo

118

Prostate Cell News@ProstateCell · Jul 11

A new study led by Dr. Nicolas Herranz (@Niko_Herranz) at @VHIO underscores the potential of CDK4/6i in #ProstateCancer therapy, particularly when administered under biology-driven sequential use of senolytic therapy or PARPi. 📌 Learn more: bit.ly/40PWkGe

ProstateCell's tweet image. A new study led by Dr. Nicolas Herranz (@Niko_Herranz) at @VHIO underscores the potential of CDK4/6i in #ProstateCancer therapy, particularly when administered under biology-driven sequential use of senolytic therapy or PARPi.

📌 Learn more: bit.ly/40PWkGe

498

Prostate Cell News@ProstateCell · Jul 10

Scientists in China have shown that TRIM26, an E3 #UbiquitinLigase, drives #ProstateCancer malignancy and may be an attractive target for treatment. 🥼 Read the study: bit.ly/40a8KIX

ProstateCell's tweet image. Scientists in China have shown that TRIM26, an E3 #UbiquitinLigase, drives #ProstateCancer malignancy and may be an attractive target for treatment. 🥼

Read the study: bit.ly/40a8KIX

Prostate Cell News@ProstateCell · Jul 9

New findings from researchers in China underscore the pivotal role of YY1 in the hypoxia/HIF-1α pathway in tumor-associated macrophages and support the targeting of YY1 for treating #ProstateCancer. 📚 Read the @NatureComms study: go.nature.com/4eF3C5r

ProstateCell's tweet image. New findings from researchers in China underscore the pivotal role of YY1 in the hypoxia/HIF-1α pathway in tumor-associated macrophages and support the targeting of YY1 for treating #ProstateCancer.

📚 Read the @NatureComms study: go.nature.com/4eF3C5r

126

Prostate Cell News@ProstateCell · Jul 8

NUSAP1 is a crucial mitotic regulator that plays a significant role in various cancers, including prostate cancer. A new #review discusses the roles and mechanisms of NUSAP1 in human cancers. 🔗 bit.ly/44DcV1d

ProstateCell's tweet image. NUSAP1 is a crucial mitotic regulator that plays a significant role in various cancers, including prostate cancer.

A new #review discusses the roles and mechanisms of NUSAP1 in human cancers.

🔗 bit.ly/44DcV1d

Prostate Cell News@ProstateCell · Jul 7

New work led by Dr. Jan-Ake Gustafsson at @UHouston shows that #EstrogenReceptor β is critical for maintenance of basal cells in the prostate and controlling prostatic inflammation. Read the @PNASNews study: bit.ly/4eB8CrL

ProstateCell's tweet image. New work led by Dr. Jan-Ake Gustafsson at @UHouston shows that #EstrogenReceptor β is critical for maintenance of basal cells in the prostate and controlling prostatic inflammation.

Read the @PNASNews study: bit.ly/4eB8CrL

Prostate Cell News@ProstateCell · Jul 7

👀 Looking for the perfect scientific career? Discover your next job with @STEMCELLTech Science News jobs board! bit.ly/4mCrryu

ProstateCell's tweet image. 👀 Looking for the perfect scientific career?

Discover your next job with @STEMCELLTech Science News jobs board!

bit.ly/4mCrryu

Prostate Cell News@ProstateCell · Jul 4

🥼 Investigators demonstrate the feasibility of using predicted structural models for optimizing lead compounds, and HEAL-116 provides a promising avenue for the clinical validation of 3βHSD1 inhibitors in prostate cancer therapy. @PNASNews | bit.ly/3IpQipq

ProstateCell's tweet image. 🥼 Investigators demonstrate the feasibility of using predicted structural models for optimizing lead compounds, and HEAL-116 provides a promising avenue for the clinical validation of 3βHSD1 inhibitors in prostate cancer therapy.

@PNASNews | bit.ly/3IpQipq

Prostate Cell News@ProstateCell · Jul 3

📖 The authors summarize the latest drug treatment strategies and clinical concerns in the management of advanced prostate cancer in Japan, based on the Japanese Clinical Practice Guidelines for Prostate Cancer published in 2023. 🔗 bit.ly/3TSzQ3z

ProstateCell's tweet image. 📖 The authors summarize the latest drug treatment strategies and clinical concerns in the management of advanced prostate cancer in Japan, based on the Japanese Clinical Practice Guidelines for Prostate Cancer published in 2023.

🔗 bit.ly/3TSzQ3z

Prostate Cell News@ProstateCell · Jul 3

💊 Researchers at @DanaFarber uncovered a common MUC1-C-dependent pathway in treatment-resistant CRPC/NEPC progression and identified MUC1-C as a target for their treatment with a M1C antibody-drug conjugate. @JCI_insight | bit.ly/4lzPH2T

ProstateCell's tweet image. 💊 Researchers at @DanaFarber uncovered a common MUC1-C-dependent pathway in treatment-resistant CRPC/NEPC progression and identified MUC1-C as a target for their treatment with a M1C antibody-drug conjugate.

@JCI_insight | bit.ly/4lzPH2T

113

Prostate Cell News@ProstateCell · Jul 1

📈 Scientists showed that dysregulated ubiquitination and turnover by the cullin 3 ZBTB2 E3 ligase complex induce the upregulation of the short isoform of NSD3, which confers PARPi resistance in prostate cancer cells and #mCRPC samples. @MolecularCell | bit.ly/4lbOXRW

ProstateCell's tweet image. 📈 Scientists showed that dysregulated ubiquitination and turnover by the cullin 3 ZBTB2 E3 ligase complex induce the upregulation of the short isoform of NSD3, which confers PARPi resistance in prostate cancer cells and #mCRPC samples.

@MolecularCell | bit.ly/4lbOXRW

Prostate Cell News@ProstateCell · Jul 1

🧬 Researchers establish FOXA1 as a multifaceted oncogene, with distinct mutational classes divergently evolving to drive prostate tumorigenesis or therapy-resistant progression. 👉 @ScienceMagazine | bit.ly/3Gis4Ng

ProstateCell's tweet image. 🧬 Researchers establish FOXA1 as a multifaceted oncogene, with distinct mutational classes divergently evolving to drive prostate tumorigenesis or therapy-resistant progression.

👉 @ScienceMagazine | bit.ly/3Gis4Ng

145